Quotables
"That’s an amazing invention, but who would ever want to use one of them?"
President Rutherford B. Hayes ; Said in 1876, after Alexander Graham Bell demonstrated the telephone to him at the White House
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7202340 | No-modified hemoglobins and uses therefor Nitrosylhemoglobin can be produced by introducing gaseous NO into an aqueous solution of hemoglobin. It has been demonstrated that nitrosylhemoglobin in aqueous solution can be converted to SNO-hemoglobin upon introduction of oxygen to the solution, as is postulated... | 04/10/2007 |
| 6207649 | Nucleoside analogs and uses in treating disease The invention relates to pharmaceutical compositions of nucleoside dimers containing an L-sugar in at least one of the nucleosides.... | 03/27/2001 |
| 6162615 | Stabilized coenzyme solutions and their use thereof for the determination of dehydrogenases or the substrate thereof in an alkaline medium Stabilized aqueous coenzyme solutions which contain up to ca. 60 mM of a heavy metal salt and optionally a complexing agent in a defined ratio to the heavy metal salt as well as their use for the determination of dehydrogenases in particular lactate dehyd... | 12/19/2000 |
| 6025335 | L-Nucleoside Dimer Compounds and therapeutic uses The invention relates to nucleoside dimers containing an L-sugar in at least one of the nucleosides and their pharmaceutical compositions.... | 02/15/2000 |
| 6020480 | Caged NADP and NAD Provided are caged NADP and NAD compounds. The invention includes two types of caged NAD and NADP (NAD/P) analogs, each type having a different caging group binding at a different site on the molecule: Phosphate-caged DMNPE-NAD/P and nicotinamide-caged CN... | 02/01/2000 |
| 5756479 | Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase The present invention provides an inhibitor of monoamine oxidase comprising a modified synthetic flavin adenine dinucleotide compound. Also provided is a method of inhibiting monoamine oxidase enzymatic activity in a cell, comprising the step of contactin... | 05/26/1998 |
| 5445942 | Amplification assay for hydrolase enzymes Hydrolase enzymes are sensitively determined using novel substituted FAD substrates. The substituted FAD substrates are hydrolysed to FAD by the enzyme to be detected. The FAD is then combined with an apoenzyme to form a holoenzyme which is used to initia... | 08/29/1995 |
| 5399681 | Method for preparing N6 -substituted NAD, NADP or FAD The invention relates to a method of preparing N6 -substituted NAD, NADP or FAD by Dimroth rearrangement, wherein the rearrangement is carried out without preceding reduction and subsequent reoxidation.... | 03/21/1995 |
| 5019496 | Photopolymerization diagnostic test composition and method for immunoassay and nucleic acid assay A diagnostic test composition for detecting and measuring an analyte possessing biologic activity comprising (a) a photocatalyst system capable of converting a monomer to a polymer upon exposure to light, the monomer capable of undergoing addition polymer... | 05/28/1991 |
| 4810635 | Specific binding assays employing label analog to reduce sample interferences A specific binding assay, e.g., immunoassay, method and reagent system wherein a structural analog of the label portion of the labeled reagent is included in the reaction mixture to interact with potentially interfering substances in the test sample. The ... | 03/07/1989 |
| 4460772 | 6-[N-(ω-Carboxyalkyl)amino]-1,3-dimethyl-5-formamidouracils Intermediates in the preparation of 9-position derivatives of theophylline useful in synthesizing theophylline immunogens and labeled conjugates. The labeled conjugates and the antibodies produced against the immunogens are particularly useful in homogene... | 07/17/1984 |
| 4255566 | Flavin adenine dinucleotide derivatives and labeled conjugates prepared therefrom A flavin adenine dinucleotide (FAD) derivative of the formula: ##STR1## wherein n is an integer from 2 through 10, and preferably is 6. The derivatives are intermediates in the preparation of FAD-labeled conjugates useful as reagents in specific bind... | 03/10/1981 |
| 4213893 | Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays Labeled conjugates of the formula: ##STR1## wherein Riboflavin--Phos)2 Ribose represents the riboflavin-pyrophosphate-ribose residue in flavin adenine dinucleotide (FAD), n=2 through 6, and --CO)L is a specifically bindable ligand, or a ... | 07/22/1980 |
| 4171432 | Flavin adenine dinucleotide-iodothyronine conjugates Conjugates of the formula: ##STR1## wherein Riboflavin-(Phos)2 -Ribose represents the riboflavin-pyrophosphate-ribose residue in flavin adenine dinucleotide (FAD), n equals 2 through 6, Y is hydrogen or trifluoroacetyl, and ଲ | 10/16/1979 |
